Visceral Leishmaniasis
Also known as: Leishmaniasis, Visceral / Leishmaniasis visceral (kala-azar) / Dumdum fever / Visceral leishmaniasis (disorder) / Kala-azar / Leishmania donovani infection / Post-kala-azar dermal leishmaniasis (disorder) / Post kala-azar dermal leishmaniasis
Drug | Drug Name | Drug Description |
---|---|---|
DB00681 | Amphotericin B | An antifungal used to treat fungal infections in neutropenic patients, cryptococcal meningitis in HIV infection, fungal infections, and leishmaniasis. |
DB09031 | Miltefosine | An antileishmanial agent used to treat leishmaniasis, a group of disease caused by parasites of the Leishmania type. |
DB05630 | Sodium stibogluconate | For the treatment of various types of a protozoal infection called leishmaniasis, which may result from sandfly bites in tropical and temperate parts of the world. Also investigated for use/treatment... |
Drug | Drug Name | Target | Type |
---|---|---|---|
DB00681 | Amphotericin B | Ergosterol | target |
DB09031 | Miltefosine | Phospholipase D1 | enzyme |
DB09031 | Miltefosine | P-glycoprotein 1 | target |
DB05630 | Sodium stibogluconate | DNA topoisomerase 1 | target |